Breaking News Instant updates and real-time market news.

ARR

ARMOUR Residential

$22.49

0.02 (0.09%)

, CIM

Chimera

$17.16

0.28 (1.66%)

07:41
11/30/16
11/30
07:41
11/30/16
07:41

Deutsche Bank to hold a conference

2016 Mortgage REIT 1:1 Day is being held in New York on November 30.

ARR

ARMOUR Residential

$22.49

0.02 (0.09%)

CIM

Chimera

$17.16

0.28 (1.66%)

EFC

Ellington Financial

$16.06

-0.17 (-1.05%)

LADR

Ladder Capital

$14.52

-0.03 (-0.21%)

MFA

MFA Financial

$7.85

0.01 (0.13%)

SLD

Sutherland Asset Management

$13.15

0.1 (0.77%)

TWO

Two Harbors

$8.67

0.19 (2.24%)

WMC

Western Asset Mortgage

$10.80

0.14 (1.31%)

  • 30

    Nov

ARR ARMOUR Residential
$22.49

0.02 (0.09%)

05/04/16
LTCO
05/04/16
DOWNGRADE
LTCO
Neutral
ARMOUR Residential downgraded to Neutral from Buy at Ladenburg
Ladenburg Thalmann analyst David Walrod downgraded ARMOUR Residential to Neutral saying the valuation is no longer compelling after the company's book value declined 12.6% to $24.48 per share in Q1.
02/24/16
NOMU
02/24/16
DOWNGRADE
Target $16
NOMU
Reduce
ARMOUR Residential downgraded to Reduce from Neutral at Nomura
Nomura analyst Brock Vandervliet downgraded ARMOUR to Reduce and lowered his price target to $16 from $23 on shares. The analyst said ARMOUR has the worst economic returns across coverage in 2015 and expects trends to continue this year given its unsuccessful portfolio construction and high leverage.
02/24/16
02/24/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Ford (F) downgraded to Underperform at Credit Suisse by analyst Dan Galves, who said the automaker's North America EBIT guidance is at risk on overly optimistic implied volumes. He also sees global inventory as conflicting with global demand and material cost increases have fully offset recent pricing/mix gains from new product launches. 2. PTC Therapeutics (PTCT) downgraded to Neutral and Sector Perform to Citi and RBC Capital, respectively, after the FDA refused to review the company's application for Translarna for the treatment of Duchenne muscular dystrophy. Citi analyst Joel Beatty said the refusal most likely suggests that PTC will need additional clinical data before refiling, which could be "expensive and risky." 3. The Advisory Board (ABCO) downgraded at Stifel, Cantor, Craig-Hallum and Avondale after the company's Q4 revenue and FY16 guidance came in below expectations. Cantor analyst Joseph Foresi said the company reported a "surprising, material slowdown" in its Healthcare growth rate and Craig-Hallum analyst Matt Hewitt added that the company's exposure on the software side as ICD-10 related revenues fell the hardest and views shares as fully valued in the near-term. 4. ARMOUR Residential (ARR) downgraded to Reduce at Nomura by analyst Brock Vandervliet, who said the company has the worst economic returns across coverage in 2015 and expects trends to continue this year given its unsuccessful portfolio construction and high leverage. 5. Yamana Gold (AUY) downgraded to Sell at Goldman, with analyst Andrew Quail saying that the company's fiscal position will "remain pressured" over the next year now that Cerro Moro has been delayed until Q1 of 2018. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/03/16
SBSH
03/03/16
UPGRADE
Target $7.14
SBSH
Neutral
JAVELIN Mortgage upgraded to Neutral from Sell at Citi
Citi analyst Donald Fandetti upgraded JAVELIN Mortgage (JMI) to Neutral citing the acquisition offer from ARMOUR Residential (ARR). The analyst raised his price target for the shares to $7.14 from $6.
CIM Chimera
$17.16

0.28 (1.66%)

05/04/16
WELS
05/04/16
DOWNGRADE
WELS
Underperform
Chimera downgraded to Underperform from Market Perform at Wells Fargo
Wells Fargo analyst Joel Houck downgraded Chimera Investment to Underperform saying the company's "premium valuation" to peers is unwarranted. The analyst expects the cost advantage of refinancing legacy residential credit deals to come under pressure in 2016 and 2017. He has a $12.25-$13.25 price target range for the shares.
01/15/16
WELS
01/15/16
DOWNGRADE
WELS
Market Perform
Chimera downgraded to Market Perform from Outperform at Wells Fargo (pre-open)
EFC Ellington Financial
$16.06

-0.17 (-1.05%)

04/21/16
04/21/16
INITIATION
Target $20.5

Outperform
Ellington Financial initiated with an Outperform at FBR Capital
Target $20.50.
LADR Ladder Capital
$14.52

-0.03 (-0.21%)

02/23/16
KBWI
02/23/16
DOWNGRADE
Target $13
KBWI
Market Perform
Ladder Capital downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Jade Rahmani downgraded Ladder Capital to Market Perform with a $13 price target citing a lack of near-term catalysts and uncertainty regarding CMBS issuance.
02/19/16
WELS
02/19/16
DOWNGRADE
WELS
Market Perform
Ladder Capital downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Joel Houck downgraded Ladder Capital to Market Perform saying the conduit lending environment remains "highly sub-optimal." The analyst has a $12.00-$12.50 price target range for the shares.
MFA MFA Financial
$7.85

0.01 (0.13%)

04/11/16
WELS
04/11/16
DOWNGRADE
WELS
Underperform
MFA Financial downgraded to Underperform from Market Perform at Wells Fargo
Wells Fargo analyst Joel Houck downgraded MFA Financial to Underperform following the release of his Q1 book value estimates for Agency REITs. The analyst lowered his price target range for the shares to $5.75-$6.25 from $6.00-$6.50.
09/06/16
09/06/16
DOWNGRADE
Target $7.5

Market Perform
MFA Financial downgraded to Market Perform from Outperform at FBR Capital
FBR Capital analyst Jessica Levi-Ribner downgraded MFA Financial to Market Perform saying the shares are fairly valued at current levels. The analyst kept a $7.50 price target for the shares.
01/26/16
01/26/16
UPGRADE

On The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AMC Entertainment (AMC) upgraded on valuation, 2017 outlook at RBC Capital... America Movil upgraded to Overweight from Equal Weight at Morgan Stanley... BNC Bancorp (BNCN) upgraded to Buy from Hold at Gabelli... Casella Waste (CWST) upgraded to Strong Buy from Outperform at Raymond James... Cenovus Energy (CVE) upgraded to Buy from Neutral at Goldman... Cracker Barrel (CBRL) upgraded to Buy from Neutral at SunTrust... D.R. Horton (DHI) upgraded to Buy from Hold at Zelman... Edison International (EIX) upgraded to Buy from Hold at Evercore ISI... First Financial Bancorp (FFBC) upgraded to Buy from Hold at Sandler O'Neill... Hartford Financial (HIG) upgraded to Overweight from Neutral at Atlantic Equities... Heartland Financial (HTLF) upgraded to Buy from Hold at Sandler O'Neill... MFA Financial (MFA) upgraded to Overweight from Neutral at JPMorgan... National General (NGHC) upgraded to Overweight at Morgan Stanley... Navios Maritime Partners (NMM) upgraded to Overweight from Neutral at JPMorgan... PG&E (PCG) upgraded to Buy from Hold at Evercore ISI... SBA Communications (SBAC) upgraded to Buy from Hold at Stifel... Sally Beauty (SBH) upgraded to Outperform from Perform at Oppenheimer... Sanmina (SANM) upgraded to Neutral from Sell at Citi... Scorpio Bulkers (SALT) upgraded to Overweight from Neutral at JPMorgan... Southern Company (SO) upgraded to Hold from Sell at Evercore ISI... Southern Copper (SCCO) upgraded to Overweight from Neutral at JPMorgan... Vodafone (VOD) upgraded to Buy from Hold at Jefferies.
06/15/16
COMP
06/15/16
DOWNGRADE
COMP
Sell
MFA Financial downgraded to Sell from Neutral at Compass Point
SLD Sutherland Asset Management
$13.15

0.1 (0.77%)

TWO Two Harbors
$8.67

0.19 (2.24%)

01/15/16
WELS
01/15/16
DOWNGRADE
WELS
Market Perform
Two Harbors downgraded to Market Perform from Outperform at Wells Fargo
11/03/16
WELS
11/03/16
UPGRADE
WELS
Outperform
Two Harbors upgraded to Outperform from Market Perform at Wells Fargo
09/06/16
09/06/16
DOWNGRADE
Target $9

Market Perform
Two Harbors downgraded to Market Perform from Outperform at FBR Capital
FBR Capital analyst Jessica Levi-Ribner downgraded Two Harbors Investment to Market Perform saying the shares are fairly valued at current levels. The analyst raised her price target for the stock to $9 from $8.50.
11/04/16
WELS
11/04/16
UPGRADE
WELS
Outperform
Two Harbors upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Joel Houck last night upgraded Two Harbors Investment to Outperform from Market Perform saying he sees a "strong case" for fundamental earnings growth following the company's Q3 results. The analyst raised his price target range for the shares to $9.00-$9.50 from $8.50-$9.00.
WMC Western Asset Mortgage
$10.80

0.14 (1.31%)

06/29/16
BOFA
06/29/16
DOWNGRADE
BOFA
Neutral
Western Asset Mortgage downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Kenneth Bruce downgraded Western Asset to Neutral and lowered its price target to $9.50 from $10. The analyst believes shares will lose their premium to the group due to declining ROE that is now in line with the group.
06/27/16
WDLK
06/27/16
UPGRADE
Target $9.5
WDLK
Hold
Western Asset Mortgage upgraded to Hold from Sell at Wunderlich
Wunderlich analyst Merrill Ross upgraded Western Asset Mortgage Capital to Hold saying the company's dividend now looks sustainable after six cuts. The analyst has a $9.50 price target for the shares.
05/10/16
WDLK
05/10/16
DOWNGRADE
Target $8
WDLK
Sell
Western Asset Mortgage downgraded to Sell from Hold at Wunderlich
Wunderlich analyst Merrill Ross downgraded Western Asset Mortgage to Sell with an $8 price target.
04/11/16
WELS
04/11/16
DOWNGRADE
WELS
Underperform
Western Asset Mortgage downgraded to Underperform from Market Perform at Wells Fargo
Wells Fargo analyst Joel Houck downgraded Western Asset Mortgage to Underperform from Market Perform following the release of his Q1 book value estimates for Agency REITs. The analyst lowered his price target range for the shares to $8.00-$8.50 from $8.50-$9.00.

TODAY'S FREE FLY STORIES

NUVA

NuVasive

$51.99

-1.34 (-2.51%)

20:43
01/16/18
01/16
20:43
01/16/18
20:43
Downgrade
NuVasive rating change at Wells Fargo »

NuVasive downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

, CELG

Celgene

$104.82

-1.18 (-1.11%)

20:38
01/16/18
01/16
20:38
01/16/18
20:38
Recommendations
Juno Therapeutics, Celgene, Acquired by GILD 9/17, Gilead analyst commentary at Citi »

Juno could be worth $110…

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

CELG

Celgene

$104.82

-1.18 (-1.11%)

KITE

Acquired by GILD 9/17

GILD

Gilead

$80.25

1.23 (1.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Jan

  • 25

    Jan

  • 12

    Feb

  • 16

    Feb

  • 25

    Mar

SNP

Sinopec

$83.07

-1 (-1.19%)

20:35
01/16/18
01/16
20:35
01/16/18
20:35
Upgrade
Sinopec rating change at Jefferies »

Sinopec upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLX

Shell Midstream

$30.74

0.21 (0.69%)

20:34
01/16/18
01/16
20:34
01/16/18
20:34
Downgrade
Shell Midstream rating change at Stifel »

Shell Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

UNH

UnitedHealth

$232.90

4.26 (1.86%)

20:31
01/16/18
01/16
20:31
01/16/18
20:31
Recommendations
UnitedHealth analyst commentary at Piper Jaffray »

UnitedHealth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

AVXS

AveXis

$105.01

-12.49 (-10.63%)

20:31
01/16/18
01/16
20:31
01/16/18
20:31
Syndicate
AveXis 3.921M share Secondary priced at $102.00 »

Goldman Sachs, Jefferies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

OZRK

Bank of the Ozarks

$52.23

-0.24 (-0.46%)

20:26
01/16/18
01/16
20:26
01/16/18
20:26
Downgrade
Bank of the Ozarks rating change at Keefe Bruyette »

Bank of the Ozarks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 30

    Jan

WP

Worldpay

$78.26

0.66 (0.85%)

, VNTV

Symbol changed to WP

20:25
01/16/18
01/16
20:25
01/16/18
20:25
Initiation
Worldpay, Symbol changed to WP initiated at Goldman Sachs »

Worldpay reinstated with…

WP

Worldpay

$78.26

0.66 (0.85%)

VNTV

Symbol changed to WP

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$31.24

0.05 (0.16%)

, GS

Goldman Sachs

$258.46

1.43 (0.56%)

20:25
01/16/18
01/16
20:25
01/16/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

BAC

Bank of America

$31.24

0.05 (0.16%)

GS

Goldman Sachs

$258.46

1.43 (0.56%)

USB

U.S. Bancorp

$57.17

0.19 (0.33%)

FAST

Fastenal

$55.44

-0.15 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 18

    Jan

  • 31

    Jan

  • 15

    Feb

C

Citi

$77.11

0.27 (0.35%)

20:20
01/16/18
01/16
20:20
01/16/18
20:20
Downgrade
Citi rating change at Keefe Bruyette »

Citi downgraded to Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 18

    Jan

  • 24

    Jan

O

Realty Income

$52.94

0.22 (0.42%)

19:12
01/16/18
01/16
19:12
01/16/18
19:12
Hot Stocks
Realty Income raises monthly dividend to 21.9c per share from 21.25c »

Realty Income announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NGD

New Gold

$3.44

0.05 (1.47%)

19:05
01/16/18
01/16
19:05
01/16/18
19:05
Hot Stocks
New Gold sees FY18 gold production 525,000-595,000 ounces »

Sees FY18 copper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NGD

New Gold

$3.44

0.05 (1.47%)

19:04
01/16/18
01/16
19:04
01/16/18
19:04
Hot Stocks
New Gold reports Q4 gold production 154,446 ounces »

Reports Q4 copper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NGD

New Gold

$3.44

0.05 (1.47%)

19:04
01/16/18
01/16
19:04
01/16/18
19:04
Hot Stocks
New Gold reports FY17 gold production 430,864 ounces »

Reports FY17 copper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$80.42

-0.12 (-0.15%)

18:50
01/16/18
01/16
18:50
01/16/18
18:50
Earnings
PayPal sees FY18 revenue $15B-$15.25B, consensus $15.35B »

Backs FY18 TPV Growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

CE

Celanese

$109.67

-1.67 (-1.50%)

18:32
01/16/18
01/16
18:32
01/16/18
18:32
Hot Stocks
Celanese increases the price of low density polyethylene to 4c »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jan

RIG

Transocean

$11.47

-0.73 (-5.98%)

18:27
01/16/18
01/16
18:27
01/16/18
18:27
Hot Stocks
Transocean shareholders show 'overwhelming support' for Songa transaction »

Transocean announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

WMT

Walmart

$100.69

-0.18 (-0.18%)

18:13
01/16/18
01/16
18:13
01/16/18
18:13
Periodicals
Wal-Mart COO to be named international CEO, Reuters says »

Wal-Mart Stores COO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

CME

CME Group

$152.20

-0.53 (-0.35%)

18:05
01/16/18
01/16
18:05
01/16/18
18:05
Hot Stocks
CME reaches daily trading volume record for Henry Hub Nat Gas futures on Jan 12 »

CME Group announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 01

    Feb

CE

Celanese

$109.67

-1.67 (-1.50%)

18:02
01/16/18
01/16
18:02
01/16/18
18:02
Hot Stocks
Celanese announces price increases for engineered materials polymer products »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jan

SRC

Spirit Realty

$8.07

-0.03 (-0.37%)

17:46
01/16/18
01/16
17:46
01/16/18
17:46
Hot Stocks
Spirit Realty funds $35M into Shopko master lease »

Spirit Realty Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTNX

Nutanix

$36.01

-1.83 (-4.84%)

17:45
01/16/18
01/16
17:45
01/16/18
17:45
Conference/Events
Nutanix management to meet with Piper Jaffray »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

, CELG

Celgene

$104.82

-1.18 (-1.11%)

17:41
01/16/18
01/16
17:41
01/16/18
17:41
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Juno Therapeutics…

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

CELG

Celgene

$104.82

-1.18 (-1.11%)

NEWA

Newater Technology

$15.80

2.8 (21.54%)

VRS

Verso

$17.00

0.06 (0.35%)

EXEL

Exelixis

$29.65

-0.73 (-2.40%)

IPSEY

Ipsen

RNST

Renasant

$43.86

0.15 (0.34%)

IBKR

Interactive Brokers

$62.45

-0.65 (-1.03%)

CSX

CSX

$58.13

-1.12 (-1.89%)

ATEN

A10 Networks

$7.31

-0.27 (-3.56%)

HTGM

HTG Molecular

$3.50

-0.14 (-3.85%)

HIVE

Aerohive

$5.70

-0.19 (-3.23%)

OBLN

Obalon Therapeutics

$7.93

0.03 (0.38%)

XON

Intrexon

$13.77

-0.94 (-6.39%)

BOOT

Boot Barn

$19.10

-0.15 (-0.78%)

F

Ford

$13.10

-0.13 (-0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 16

    Jan

  • 16

    Jan

  • 17

    Jan

  • 18

    Jan

  • 19

    Jan

  • 19

    Jan

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

  • 08

    Feb

  • 08

    Feb

  • 15

    Feb

  • 16

    Feb

  • 26

    Feb

  • 01

    Mar

  • 25

    Mar

  • 17

    Jan

  • 18

    Jan

  • 19

    Jan

  • 19

    Jan

NRZ

New Residential

$17.63

-0.11 (-0.62%)

17:35
01/16/18
01/16
17:35
01/16/18
17:35
Earnings
Breaking Earnings news story on New Residential »

New Residential sees Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

EXEL

Exelixis

$29.65

-0.73 (-2.40%)

17:30
01/16/18
01/16
17:30
01/16/18
17:30
Hot Stocks
Breaking Hot Stocks news story on Exelixis »

Exelixis up 3.2%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 19

    Jan

  • 19

    Jan

  • 25

    Jan

  • 08

    Feb

  • 15

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.